Lymphocyte recovery following allogeneic stem cell transplantation: New possibilities for improvement

Clinical and Applied Immunology Reviews

Volumn 2, Issue 4-5, 2002, Pages 217-227

  Broers, Annoek E C ^a   Gratama, Jan W ^a   Löwenberg, Bob ^a   Cornelissen, Jan J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Allo SCT; GVHD; Immune reconstitution; Lymphocytes

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; HLA ANTIGEN;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; APLASTIC ANEMIA; B LYMPHOCYTE; BLOOD DONOR; CANCER MORTALITY; GRAFT VERSUS HOST REACTION; GRANULOCYTE; HEMATOLOGIC DISEASE; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; IMMUNE DEFICIENCY; IMMUNOCOMPETENCE; LEUKOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; LYMPHOCYTE FUNCTION; LYMPHOCYTOPENIA; OPPORTUNISTIC INFECTION; REVIEW; RISK ASSESSMENT; T LYMPHOCYTE; TREATMENT OUTCOME;

EID: 0036663442     PISSN: 15291049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1529-1049(02)00047-8     Document Type: Review

References (78)

1. Gratwohl A, Passweg J, Baldomero H, Hermans J. Blood and marrow transplantation activity in Europe 1997. European Group Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 1999;24:231-45.
2. Kernan NA, Bartsch G, Ash RC, Beatty PG, Champlin R, Filipovich A, et al. Analysis of 462 transplantations from unrelated donors facilitated by the national marrow donor program. N Engl J Med 1993;328:593-602.
3. Sierra J, Storer B, Hansen JH, Bjerke JW, Martin PJ, et al. Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching and marrow cell dose. Blood 1997;89:4226-35.
4. Cornelissen JJ, Carston M, Kollman C, King R, Dekker AW, Löwenberg B, et al. Unrelated marrow transplantation for adult patients with poor-risk acute lymphoblastic leukemia: strong graft-versus-leukemia effect and risk factors determining outcome. Blood 2001;97:1572-7.
5. Aversa F, Tablio A, Velardi A, Cunningham I, Terenzi A, Falzetti F, et al. Treatment of high-risk acute leukemia with T-cell depleted stem cells from related donors with only fully mismatched HLA haplotype. N Engl J Med 1998;339:1186-93.
6. Gluckman E, Rocha V, Chevret S. Results of unrelated cord blood hematopoietic stem cell transplantation. Rev Clin Exp Hematol 2001;5:87-99.
7. Dazzi F, Szydlo RM, Goldman JM. Donor lymphocyte infusions for relapse of chronic myeloid leukemia after allogeneic stem cell transplant: where we now stand. Exp Hematol 1999;27:1477-86.
8. Childs R, Chernoff A, Contentin N, Bahceci E, Schrump D, Leitman S, et al. Regression of metastatic renalcell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation. N Engl J Med 2000;343:750-8.
9. Verdonck LF. Allogeneic versus autologous bone marrow transplantation for refractory and recurrent lowgrade non-Hodgkin's lymphoma: updated results of the Utrecht experience. Leuk Lymphoma 1999;34:129-36.
10. Gratwohl A, Hermans J, Goldman JM, Arcese W, Carreras E, Devergie A, et al. Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the Group for Blood and Marrow Transplantation. Lancet 1998;352:1087-92.
11. Storek J, Witherspoon RP. Immunological reconstitution after hemopoietic stem cell transplantation. In: Atkinson K, editor. Clinical Bone Marrow and Blood Stem Cell Transplantation: A Reference Textbook. 2nd ed. Cambridge, England: Cambridge University Press; 2000. p. 111-146.
12. Atkinson K, Storb R, Prentice RL, Weiden PL, Witherspoon RP, Sullivan K, et al. Analysis of late infections in 89 long-term survivors of bone marrow transplantation. Blood 1979;53:720-31.
13. + selected grafts with recipients of unmanipulated grafts. Exp Hematol 1999;27:561-8.
14. + selected PBPC grafts, unselected PBPC grafts or BM grafts. Bone Marrow Transplant 1999;24:295-302.
15. Frassoni F, Labopin M, Gluckman E, Prentice HG, Vernant JP, Zwaan F, et al. Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time - a report of the Acute Leukemia Working Party of the European Group for Blood and Bone Marrow Transplantation (EBMT). Bone Marrow Transplant 1996;17:13-8.
16. Storek J, Dawson MA, Storer B, Stevens-Ayers T, Maloney DC, Marr KA, et al. Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation. Blood 2001;97:3380-9.
17. Storek J, Wells D, Dawson MA, Storer B, Maloney DG. Factors influencing B lymphopoiesis after allogeneic hematopoietic cell transplantation. Blood 2001;98:489-91.
18. Small TN, Keever CA, Weiner-Fedus S, Heller G, O'Reilly RJ, Flomenberg N. B-cell differentiation following autologous, conventional, or T-cell depleted bone marrow transplantation: a recapitulation of normal B-cell ontogeny. Blood 1990;76:1647-56.
19. Storek J, Ferrara S, Ku N, Giorgi JV, Champlin RE, Saxon A. B cell reconstitution after human bone marrow transplantation: recapitulation of ontogeny? Bone Marrow Transplant 1993;12:387-98.
20. Storek J, Witherspoon RP, Storb R. Reconstitution of membrane IgD- (mIgD-) B cells after marrow transplantation lags behind the reconstitution of mIgD+ B cells (letter). Blood 1997;89:350-1.
21. Storek J, King L, Ferrara S, Marcelo D, Saxon A, Braun J. Abundance of a restricted fetal B cell repertoire in marrow transplant recipients. Bone Marrow Transplant 1994;14:783-90.
22. Velardi A, Cucciaioni S, Terenzi A, Quinti I, Aversa F, Grossi CE, et al. Acquisition of Ig isotype diversity after bone marrow transplantation in adults. A recapitulation of normal B cell ontogeny. J Immunol 1998; 141:815-20.
23. Sheridan JF. Immunoglobin G subclass deficiency and pneumococcal infection after allogeneic BMT. Blood 1990;75:1583-6.
24. Aucouturier P, Barra A, Intrator L, Cordonnier C, Schulz D, Duarte F, et al. Long lasting IgG subclass and antibacterial polysaccharide antibody deficiency after allogeneic bone marrow transplantation. Blood 1987; 70:779-85.
25. Noel DR, Witherspoon RB, Storb R, Atkinson K, Doney K, Mickelson EM, et al. Does graft-versus-host disease influence the tempo of immunologic recovery after allogeneic human marrow transplantation? An observation of 56 long-term survivors. Blood 1978;51:1081-105.
26. Ljungman P, Wiklund-Hammarsten M, Duraj V, Hammarstrom L, Lonnqvist B, Paulin T, et al. Response to tetanus toxoid immunization after allogeneic bone marrow transplantation. J Infect Dis 1990;162:496-500.
27. Witherspoon RP, Storb R, Ochs HD, Fluornoy N, Kopecky KJ, Sullivan KM, et al. Recovery of antibody production in human allogeneic marrow graft recipients: influence of time posttransplantation, the presence or absence of chronic graft-versus-host-disease, and antithymocyte globulin treatment. Blood 1981;58:360-8.
28. Weinberg K, Annett G, Kashyap A, Lenarsky C, Forman SJ, Parkman R. The effect of thymic function on immunocompetence following bone marrow transplantation. Biol Blood Marrow Transplant 1995;1:18-23.
29. Small TN, Papadopoulos EB, Boulad F, Black P, Castro-Malaspina H, Childs BH, et al. Comparison of immune reconstitution after unrelated and related T-cell depleted bone marrow transplantation: effect of patient age and donor leukocyte infusions. Blood 1999;93:467-80.
30. Storek J, Golley T, Witherspoon RP, Sullivan KM, Storb R. Infectious morbidity in long-term survivors of allogeneic marrow transplantation is associated with low CD4 T cell counts. Am J Hematol 1997;54:131-8.
31. Storek J, Witherspoon RP, Storb R. T cell reconstitution after bone marrow transplantation into adult patients does not resemble T cell development in early life. Bone Marrow Transplant 1995;16:413-25.
32. Kook H, Goldman F, Padley D, Guller R, Rummerhart S, Holida M, et al. Reconstitution of the immune system after unrelated or partially marched T cell depleted bone marrow transplantation in children: immunophenotypic analysis and factors affecting the speed of recovery. Blood 1996;88:1089-97.
33. Roux E, Dumont-Girard F, Starobinski M, Siegrist CA, Heig C, Chapuis B, et al. Recovery of immune reactivity after T-cell depleted bone marrow transplantation depends on thymic activity. Blood 2000;96:2299-303.
34. Keever CA, Small TN, Flomenberg N, Heller G, Pekle K, Black P, et al. Immune reconstitution following bone marrow transplantation: Comparison of recipients of T-cell depleted marrow with recipients of conventional marrow grafts. Blood 1989;73:1340-50.
35. Gratama JW, Naipal A, Oljans P, Zwaan FE, Verdonck LF, de Witte T, et al. T lymphocyte repopulation and differentiation after bone marrow transplantation. Early shifts in the ratio between T4+ and T8+ T lymphocytes correlate with the occurrence of acute GVHD. Blood 1984;63:1416-23.
36. Sullivan KM, Storek J, Kopecky KJ, Jocom J, Longton G, Flowers M, et al. A controlled trial of long-term administration of intravenous immunoglobulin to prevent late infection and chronic GVHD following marrow transplantation: clinical outcome and effect on subsequent immune recovery. Biol Blood Marrow Transplant 1996;2:44-53.
37. Friedrich W, O'Reilly RJ, Koziner B, Gebhard DF, Good RA, Evans RL. T-lymphocyte reconstitution in recipients of bone marrow transplants with and without GVHD: imbalances of T cell subpopulations having unique regulatory and cognitive functions. Blood 1982;59:696-701.
38. Small TN, Avigan D, Dupont B, Smith K, Black P, Heller G, et al. Immune reconstitution following T-cell depleted bone marrow transplantation: effect of age and post-transplant graft rejection prophylaxis. Biol Blood Marrow Transplant 1997;3:65-75.
39. Tough DF, Sprent J. Turnover of naive- and memory-phenotype T cells. J Exp Med 1994;179:1127-35.
40. Kong F-K, Chen CL-H, Cooper MD. Thymic function can be accurately monitored by the level of recent T cell emigrants in the circulation. Immunity 1998;8:97-104.
41. Takeshita S, Masaaki T, Yamagishi H. Excision products of T cell receptor gene support a progressive rearrangement model of the α/δ locus. EMBO J 1989;8:3261-70.
42. Livak F, Schatz D. T-cell receptor α locus V (D) J recombination by-products are abundant in thymocytes and mature T cells. Mol Cell Biol 1996;16:609-18.
43. Douek DC, McFarland RD, Keiser PH, Gage EA, Massey JM, Haynes BF, et al. Changes in thymic function with age and during treatment of HIV infection. Nature 1998;396:690-4.
44. Douek DC, Vesico RA, Betts MR, Brenchley JM, Hill BJ, Zhang L, et al. Assessment of thymic output in adults after haematopoietic stem cell transplantation and prediction of T-cell reconstitution. Lancet 2000;355:1875-81.
45. Hazenberg MD, Otto SA, Cohen Stuart JW, Verschuren MC, Borleffs JC, Boucher CA. et al. Increased cell division but not thymice dysfunction rapidly affects the T-cell receptor excision circle content of the naive T cell population in HIV-1 infection. Nat Med 2000;6:1036-42.
46. Weinberg K, Blazar BR, Wagner JE, Agura E, Hill BJ, Smogorzewska M, et al. Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation. Blood 2001;97:1458-66.
47. Atkinson K, Hansen JA, Storb R, Goehle S, Goldstein G, Thomas ED. T cell subpopulations identified by monoclonal antibodies after human marrow transplantation. I. Helper-inducer and cytotoxic-suppressor subsets. Blood 1982;59:1292-7.
48. Fukuda H, Nakamura H, Tominaga N, Teshima H, Hiraoka A, Shibata H, et al. Marked increase of CD8+S6F1+ and CD8+Cd57+ cells in patients with GVHD after allogeneic BMT. Bone Marrow Transplant 1994;13:181-5.
49. Reusser P, Riddel SR, Meyers JD, Greenberg PD. Cytotoxic T-lymphocyte response to CMV after human allogeneic BMT: pattern of recovery and correlation with CMV infection and disease. Blood 1991;78:1373-80.
50. Li CR, Greenberg PD, Gilbert MJ, Goodrich JM, Riddell SR. Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis. Blood 1994;83:1971-9.
51. Van Esser JWJ, Van der Holt B, Meijer E, Niesters HGM, Trenschel R, Thijsen SFT, et al. Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell-depleted SCT. Blood 2001;98:972-8.
52. Quinnan GVJ, Kirmani N, Rook AH, Manischewitz JF, Jackson L, Moreschi G, et al. HLA-restricted T-lymphocyte and non T-lymphocyte cytotoxic responses correlate with recovery from CMV infection in BMT recipients. N Engl J Med 1982;307:7-13.
53. Gratama JW, Van Esser JWJ, Lamers CHJ, et al. Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation: identification of patients at risk for progressive CMV infection. Blood 2001;98(5):1358-64.
54. Van Esser JWJ, Niesters HG, Thijsen SF, Meijer E, Osterhaus AD, Wolthers KC, et al. Molecular quantitation of viral load in plasma allows for fast and accurate prediction of response to therapy of Epstein-Barr virus-associated lymphoproliferative disease after allogeneic stem cell transplantation. Br J Haematol 2001;113:814-21.
55. Walter EA, Greenberg PD, Gilbert MJ, Finch RJ, Watanabe KS, Thomas ED, et al. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med 1995;333:1038-44.
56. O'Reilly RJ, Small TN, Papadoupolos E, Lucas K, Lacerda J, Koulova L. Adoptive immunotherapy for Epstein-Barr virus-associated lymphoproliferative disorders complicating marrow allografts. Springer Semin Immunopathol 1998;20:455-91.
57. Heslop PE, Perez M, Benaim E, Rochester R, Brenner MK, Rooney CM. Transfer of EBV-specific CTL to prevent EBV lymphoma post bone marrow transplant. J Clin Apheresis 1999;14:154-6.
58. Einsele H, Hebart H. Cytomegalovirus infection following stem cell transplantation. Haematologica 1999; 84:46-9.
59. + cytotoxic T cells responses during chronic viral infection. J Virol 1994;68:8056-63.
60. Noel DR, Witherspoon RP, Storb R, Atkinson K, Doney K, Mickelson EM, et al. Does graft-versus-host-disease influence the tempo of immunologic recovery after allogeneic human marrow transplantation? An observation on long-term survivors. Blood 1978;51:1087-105.
61. Mackall CL, Granger L, Sheard MA, Cepeda R, Gress RE. T-cell regeneration after bone marrow transplantation: differential CD45 isoform expression on thymic-derived versus thymic-independent progeny. Blood 1993; 82:2585-94.
62. Seddik M, Seemayer TA, Lapp WS. T cell functional defect associated with thymic epithelial cell injury induced by a graft-versus-host reaction. Transplantation 1980;29:61-6.
63. Seddik M, Seemayer TA, Lapp WS. The graft-versus-host reaction and immune function. Transplantation 1984;37:281-6.
64. Van den Brink MRM, Moore E, Ferrara JLM, Burakoff SJ. Graft-versus-host-disease-associated thymic damage results in the appearance of T cell clones with anti-host reactivity. Transplantation 1999;69:446-9.
65. Champlin RE, Schmitz N, Horowitz MM, Chapuis B, Chopra R, Cornelissen JJ, et al. Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. Blood 2000;95:3702-9.
66. Ottinger HD, Beelen DW, Scheulen B, Schaefer UW, Grosse-Wilde H. Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow. Blood 1996;88:2775-9.
67. Cornelissen JJ, Löwenberg B. Developments in T-cell depletion of allogeneic stem cell grafts. Curr Opin Hematol 2000;7:348-52.
68. Peggs K, Verfuert S, Mackinnon S. Induction of cytomegalovirus (CMV)-specific T-cell responses using dendritic cells pulsed with CMV antigen: a novel culture system free of live CMV virions. Blood 2001;97: 994-1000.
69. Min D, Taylor P, Chung B, Panoskaltsis-Mortairi A, Farell C, Lacey D, et al. Protection from thymic epithelial cell (TEC) injury by pre-BMT keratinocyte growth gractor (KGF): a new approach to speed thymic reconstitution after lethal irradiation. Blood 2000;96:474a(#2039).
70. Von Freeden-Jeffry U, Vieira P, Lucian LA, McNeil T, Burdach SE, Murray R. Lymphopenia in interleukin (IL)-7 gene deleted mice identifies IL-7 as a nonredundant cytokine. J Exp Med 1995;181:1518-26.
71. Von Freeden-Jeffry U, Solvason N, Howard M, Murray R. The earliest T lineage committed cells depend on IL-7 for Bcl-2 expression and normal cell cycle progression. Immunity 1997;7:147-54.
72. Schluns KS, Kieper WC, Jameson SC, Lefrancois L. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat Immunol 2000;1:426-32.
73. Abdul-Hai A, Or R, Slavin S, Friedman G, Weiss L, Matsa D, et al. Stimulation of immune reconstitution by interleukin-7 after syngeneic bone marrow transplantation in mice. Exp Hematol 1996;24:1416-22.
74. Bolotin E, Smogorzewska M, Smith S, Widmer M, Weinberg K. Enhancement of thymopoiesis after bone marrow transplantation by in vivo interleukin-7. Blood 1996;88:1887-94.
75. Levy RB, Jones M, Hamilton BL, Paupe J, Horowitz T, Riley R. IL-7 drives donor T-cell proliferation and can costimulate cytokine secretion after MHC-matched allogeneic bone marrow transplantation. J Immunol 1995;154:106-15.
76. Alpdogan O, Schmaltz C, Muriglan SJ, Kappel BJ, Perales MA, Rotolo JA, et al. Adminstration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host disease. Blood 2001;98:2256-65.
77. Mackall CL, Fry TJ, Bare C, Morgan P, Galbraith A, Gress RE. IL-7 increases both thymic-dependent and thymic-independent T-cell regeneration after bone marrow transplantation. Blood 2001;97:1491-7.
78. Fry TJ, Christensen BL, Komschlies KL, Gress RE, Mackall CL. Interleukin-7 restores immunity in athymic T-cell depleted hosts. Blood 2001;97:1525-33.